Myocardial infarction secondary to 5-fluorouracil: Not an absolute contraindication to rechallenge?

被引：25
作者：
Rateesh, Shruti [1 ]
Luis, Sushil A. [1 ,2 ,4 ]
Luis, Chris R. [1 ]
Hughes, Brett [3 ]
Nicolae, Mugur [1 ]
机构：
[1] Prince Charles Hosp, Dept Cardiol, Chermside, Qld, Australia
[2] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA
[3] Prince Charles Hosp, Dept Oncol, Chermside, Qld, Australia
[4] Univ Queensland, Sch Med, Herston, Qld, Australia
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2014年 / 172卷 / 02期
关键词：
Myocardial infarction; Coronary vasospasm; Cancer; 5-Fluorouracil; Chemotherapy; Colon cancer; PAN-EUROPEAN TRIAL; COLON-CANCER; CARDIOTOXICITY;
D O I：
10.1016/j.ijcard.2013.12.274
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E331 / E333
页数：3
相关论文
共 8 条
[1]   Coronary Vasospasm with Myocardial Stunning in a Patient with Colon Cancer Receiving Adjuvant Chemotherapy with FOLFOX Regimen [J].
Cerny, Jan ;
Hassan, Amr ;
Smith, Craig ;
Piperdi, Bilal .
CLINICAL COLORECTAL CANCER, 2009, 8 (01) :55-58
[2]   Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity [J].
Cianci, G ;
Morelli, MF ;
Cannita, K ;
Morese, R ;
Ricevuto, E ;
Di Rocco, ZC ;
Porzio, G ;
Baldi, PL ;
Ficorella, C .
BRITISH JOURNAL OF CANCER, 2003, 88 (10) :1507-1509
[3]   A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colon Cancer 2 study [J].
Koehne, Claus-Henning ;
Bedenne, Laurent ;
Carrato, Alfredo ;
Bouche, Olivier ;
Popov, Ivan ;
Gaspa, Losa ;
Valladares, Manuel ;
Rougier, Phillipe ;
Gog, Christiane ;
Reichardt, Peter ;
Wils, Jacques ;
Pignatti, Francesco ;
Biertz, Frank .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) :1868-1875
[4]   FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
TANGEN, CM ;
UNGERLEIDER, JS ;
EMERSON, WA ;
TORMEY, DC ;
GLICK, JH ;
VEEDER, MH ;
MAILLIARD, JA .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (05) :321-326
[5]   Raltitrexed (Tomudex®) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1) [J].
Popov, Ivan ;
Carrato, Alfredo ;
Sobrero, Alberto ;
Vincent, Mark ;
Kerr, David ;
Labianca, Roberto ;
Bianco, Angelo Raffaele ;
El-Serafi, Mostafa ;
Bedenne, Laurent ;
Paillot, Bernard ;
Mini, Enrico ;
Sanches, Evaristo ;
Welch, John ;
Collette, Laurence ;
Praet, Michel ;
Wils, Jacques .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (15) :2204-2211
[6]   5-fluorouracil induced cardiotoxicity: Review of the literature [J].
Sorrentino, Michael F. ;
Kim, Jiwon ;
Foderaro, Andrew E. ;
Truesdell, Alexander G. .
CARDIOLOGY JOURNAL, 2012, 19 (05) :453-458
[7]   5-fluorouracil induces arterial vasocontractions [J].
Südhoff, T ;
Enderle, MD ;
Pahlke, M ;
Petz, C ;
Teschendorf, C ;
Graeven, U ;
Schmiegel, W .
ANNALS OF ONCOLOGY, 2004, 15 (04) :661-664
[8]  
Suresh V, 2005, HEART, V90, P439
1